Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Journal of Obesity
Volume 2015, Article ID 343479, 21 pages
http://dx.doi.org/10.1155/2015/343479
Research Article

Genetic and Diet-Induced Obesity Increased Intestinal Tumorigenesis in the Double Mutant Mouse Model Multiple Intestinal Neoplasia X Obese via Disturbed Glucose Regulation and Inflammation

Department of Food, Water and Cosmetics, Division of Environmental Medicine, Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, 0403 Oslo, Norway

Received 13 February 2015; Revised 17 June 2015; Accepted 8 July 2015

Academic Editor: B. J. Ammori

Copyright © 2015 Ha Thi Ngo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Organisation for Economic Co-operation and Development (OECD), Health at a Glance 2013, OECD Indicators, OECD, 2013, http://www.oecd.org/els/health-systems/Health-at-a-Glance-2013.pdf.
  2. Cancer Registry of Norway, Cancer in Norway 2012. Cancer Incidence, Mortality, Survival and Prevalence in Norway, Cancer Registry of Norway, Oslo, Norway, 2014, http://www.kreftregisteret.no/Global/Cancer%20in%20Norway/2012/CIN_2012.pdf.
  3. A. R. Moser, H. C. Pitot, and W. F. Dove, “A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse,” Science, vol. 247, no. 4940, pp. 322–324, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. L.-K. Su, K. W. Kinzler, B. Vogelstein et al., “Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene,” Science, vol. 256, no. 5057, pp. 668–670, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. B. M. Boman and J. Z. Fields, “An APC:WNT counter-current-like mechanism regulates cell division along the human colonic crypt axis: a mechanism that explains how APC mutations induce proliferative abnormalities that drive colon cancer development,” Frontiers in Oncology, vol. 3, Article ID 244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nelson and I. S. Näthke, “Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance,” Journal of Cell Science, vol. 126, no. 4, pp. 873–877, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. E. R. Fearon, “Molecular genetics of colorectal cancer,” The Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 479–507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Al-Sohaily, A. Biankin, R. Leong, M. Kohonen-Corish, and J. Warusavitarne, “Molecular pathways in colorectal cancer,” Journal of Gastroenterology and Hepatology, vol. 27, no. 9, pp. 1423–1431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Ingalls, M. M. Dickie, and G. D. Snell, “Obese, a new mutation in the house mouse,” The Journal of Heredity, vol. 41, no. 12, pp. 317–318, 1950. View at Google Scholar · View at Scopus
  10. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, “Positional cloning of the mouse obese gene and its human homologue,” Nature, vol. 372, no. 6505, pp. 425–432, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. F. F. Chehab, J. Qiu, and S. Ogus, “The use of animal models to dissect the biology of leptin,” Recent Progress in Hormone Research, vol. 59, pp. 245–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. The Jackson Laboratory, JAX Mice Database—000632 B6.Cg-Lepob/J, The Jackson Laboratory, 2014, http://jaxmice.jax.org/strain/000632.html.
  13. J. M. Friedman and J. L. Halaas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. H. A. J. Schut and E. G. Snyderwine, “DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis,” Carcinogenesis, vol. 20, no. 3, pp. 353–368, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. I.-L. Steffensen, J. E. Paulsen, T. J. Eide, and J. Alexander, “2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice,” Carcinogenesis, vol. 18, no. 5, pp. 1049–1054, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Paulsen, I.-L. Steffensen, Å. Andreassen, R. Vikse, and J. Alexander, “Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice,” Carcinogenesis, vol. 20, no. 7, pp. 1277–1282, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, Å. Andreassen, and J. Alexander, “Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts,” Cancer Research, vol. 61, no. 24, pp. 8689–8696, 2001. View at Google Scholar · View at Scopus
  18. A. R. Moser, A. R. Shoemaker, C. S. Connelly et al., “Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation,” Developmental Dynamics, vol. 203, no. 4, pp. 422–433, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. H. T. Ngo, R. B. Hetland, A. Sabaredzovic, L. S. Haug, and I.-L. Steffensen, “In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice,” Environmental Research, vol. 132, pp. 251–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. World Health Organization, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation, WHO, Geneva, Switzerland, 2006, http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf.
  21. K. El-Haschimi and H. Lehnert, “Leptin resistance—or why leptin fails to work in obesity,” Experimental and Clinical Endocrinology and Diabetes, vol. 111, no. 1, pp. 2–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Kim, E. J. Kim, S.-W. Seo, C.-G. Hur, R. A. McGregor, and M.-S. Choi, “Meta-review of protein network regulating obesity between validated obesity candidate genes in the white adipose tissue of high-fat diet-induced obese C57BL/6J mice,” Critical Reviews in Food Science and Nutrition, vol. 54, no. 7, pp. 910–923, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Laake, I. Thune, R. Selmer, S. Tretli, M. L. Slattery, and M. B. Veierød, “A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon,” Cancer Epidemiology Biomarkers & Prevention, vol. 19, no. 6, pp. 1511–1522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Levi, J. D. Kark, M. Barchana et al., “Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males,” Cancer Epidemiology Biomarkers & Prevention, vol. 20, no. 12, pp. 2524–2531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Ajouz, D. Mukherji, and A. Shamseddine, “Secondary bile acids: an underrecognized cause of colon cancer,” World Journal of Surgical Oncology, vol. 12, no. 1, article 164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Gravaghi, J. Bo, K. M. D. LaPerle et al., “Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice,” International Journal of Obesity, vol. 32, no. 11, pp. 1716–1719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Hata, M. Kubota, M. Shimizu et al., “C57Bl/KsJ-db/db-ApcMin/+ mice exhibit an increased incidence of intestinal neoplasms,” International Journal of Molecular Sciences, vol. 12, no. 11, pp. 8133–8145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Khandekar, P. Cohen, and B. M. Spiegelman, “Molecular mechanisms of cancer development in obesity,” Nature Reviews Cancer, vol. 11, no. 12, pp. 886–895, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. L. Prieto-Hontoria, P. Pérez-Matute, M. Fernández-Galilea, M. Bustos, J. A. Martínez, and M. J. Moreno-Aliaga, “Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach,” Biochimica et Biophysica Acta, vol. 1807, no. 6, pp. 664–678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. R. Guffey, D. Fan, U. P. Singh, and E. A. Murphy, “Linking obesity to colorectal cancer: recent insights into plausible biological mechanisms,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 5, pp. 595–600, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. D. Hursting, “Obesity, energy balance, and cancer: a mechanistic perspective,” in Advances in Nutrition and Cancer, V. Zappia, S. Panico, G. L. Russo, A. Budillon, and F. D. Ragione, Eds., vol. 159 of Cancer Treatment and Research, pp. 21–33, Springer, Berlin, Germany, 2014. View at Google Scholar
  32. World Cancer Research Fund/American Institute for Cancer Research, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective, World Cancer Research Fund/American Institute for Cancer Research, Washington, DC, USA, 2007, http://www.dietandcancerreport.org/cancer_resource_center/downloads/Second_Expert_Report_full.pdf.
  33. World Cancer Research Fund/American Institute for Cancer Research, Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer, World Cancer Research Fund/American Institute for Cancer Research, Washington, DC, USA, 2011, http://www.dietandcancerreport.org/cancer_resource_center/downloads/cu/Colorectal-Cancer-2011-Report.pdf.
  34. H. Kwon and J. E. Pessin, “Adipokines mediate inflammation and insulin resistance,” Frontiers in Endocrinology, vol. 4, article 71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C. H. Jung and M.-S. Kim, “Molecular mechanisms of central leptin resistance in obesity,” Archives of Pharmacal Research, vol. 36, no. 2, pp. 201–207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zhou and L. Rui, “Leptin signaling and leptin resistance,” Frontiers of Medicine, vol. 7, no. 2, pp. 207–222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Uddin, A. R. Hussain, O. S. Khan, and K. S. Al-Kuraya, “Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis,” Tumor Biology, vol. 35, no. 2, pp. 871–879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Liu, T. Uesaka, H. Watanabe, and N. Kato, “High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin,” International Journal of Oncology, vol. 19, no. 5, pp. 1009–1014, 2001. View at Google Scholar · View at Scopus
  39. T. Jaffe and B. Schwartz, “Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways,” International Journal of Cancer, vol. 123, no. 11, pp. 2543–2556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Somasundar, A. K. Yu, L. Vona-Davis, and D. W. McFadden, “Differential effects of leptin on cancer in vitro,” Journal of Surgical Research, vol. 113, no. 1, pp. 50–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Aparicio, S. Guilmeau, H. Goiot et al., “Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa,” Gastroenterology, vol. 126, no. 2, pp. 499–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. K. N. Ealey, S. Lu, and M. C. Archer, “Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter,” Molecular Carcinogenesis, vol. 47, no. 9, pp. 667–677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Endo, K. Hosono, T. Uchiyama et al., “Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis,” Gut, vol. 60, no. 10, pp. 1363–1371, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Garbarino and S. L. Sturley, “Saturated with fat: new perspectives on lipotoxicity,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 2, pp. 110–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. H. J. Renaud, J. Y. Cui, H. Lu, and C. D. Klaassen, “Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis,” PLoS ONE, vol. 9, no. 2, Article ID e88584, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. H. K. Vincent, K. E. Innes, and K. R. Vincent, “Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity,” Diabetes, Obesity and Metabolism, vol. 9, no. 6, pp. 813–839, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. M. Watson and R. N. DuBois, “Lipid metabolism and APC: implications for colorectal cancer prevention,” The Lancet, vol. 349, no. 9050, pp. 444–445, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Li, H. Edamatsu, R. Kitazawa, S. Kitazawa, T. Kataoka, and M. Li, “Phospholipase Cε promotes intestinal tumorigenesis of ApcMin/+ mice through augmentation of inflammation and angiogenesis,” Carcinogenesis, vol. 30, no. 8, pp. 1424–1432, 2009. View at Publisher · View at Google Scholar
  49. D. W. Kang, K.-Y. Choi, and D. S. Min, “Phospholipase D meets Wnt signaling: a new target for cancer therapy,” Cancer Research, vol. 71, no. 2, pp. 293–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. W. C. Willett, “Dietary fat intake and cancer risk: a controversial and instructive story,” Seminars in Cancer Biology, vol. 8, no. 4, pp. 245–253, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. I. F. Godsland, “Insulin resistance and hyperinsulinaemia in the development and progression of cancer,” Clinical Science, vol. 118, no. 5, pp. 315–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. V. T. Samuel and G. I. Shulman, “Mechanisms for insulin resistance: common threads and missing links,” Cell, vol. 148, no. 5, pp. 852–871, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Pollak, “Insulin and insulin-like growth factor signalling in neoplasia,” Nature Reviews Cancer, vol. 8, no. 12, pp. 915–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Gao, Y. S. Chang, B. Jallal, and J. Viner, “Targeting the insulin-like growth factor axis for the development of novel therapeutics in oncology,” Cancer Research, vol. 72, no. 1, pp. 3–12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. S. E. Shoelson, L. Herrero, and A. Naaz, “Obesity, inflammation, and insulin resistance,” Gastroenterology, vol. 132, no. 6, pp. 2169–2180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Amitani, A. Asakawa, H. Amitani, and A. Inui, “The role of leptin in the control of insulin-glucose axis,” Frontiers in Neuroscience, vol. 7, article 51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. A. M. van den Hoek, B. Teusink, P. J. Voshol, L. M. Havekes, J. A. Romijn, and H. Pijl, “Leptin deficiency per se dictates body composition and insulin action in ob/ob mice,” Journal of Neuroendocrinology, vol. 20, no. 1, pp. 120–127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Zhou and G. K. Hansson, “Effect of sex and age on serum biochemical reference ranges in C57BL/6J mice,” Comparative Medicine, vol. 54, no. 2, pp. 176–178, 2004. View at Google Scholar · View at Scopus
  60. R. Rexhepaj, A. Rotte, S. Gu et al., “Tumor suppressor gene adenomatous polyposis coli downregulates intestinal transport,” Pflugers Archiv-European Journal of Physiology, vol. 461, no. 5, pp. 527–536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. S. E. Ross, N. Hemati, K. A. Longo et al., “Inhibition of adipogenesis by Wnt signaling,” Science, vol. 289, no. 5481, pp. 950–953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. C. N. Bennett, S. E. Ross, K. A. Longo et al., “Regulation of Wnt signaling during adipogenesis,” The Journal of Biological Chemistry, vol. 277, no. 34, pp. 30998–31004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. H. J. Welters and R. N. Kulkarni, “Wnt signaling: relevance to β-cell biology and diabetes,” Trends in Endocrinology and Metabolism, vol. 19, no. 10, pp. 349–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. R. A. Koza, L. Nikonova, J. Hogan et al., “Changes in gene expression foreshadow diet-induced obesity in genetically identical mice,” PLoS genetics, vol. 2, no. 5, article e81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler, “Insulin resistance, apoptosis, and colorectal adenoma risk,” Cancer Epidemiology, Biomarkers & Prevention, vol. 14, no. 9, pp. 2076–2081, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Bao, K. Nimptsch, J. A. Meyerhardt et al., “Dietary insulin load, dietary insulin index, and colorectal cancer,” Cancer Epidemiology, Biomarkers & Prevention, vol. 19, no. 12, pp. 3020–3026, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Cancello and K. Clément, “Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 113, no. 10, pp. 1141–1147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. Liu, R. S. Brooks, E. D. Ciappio et al., “Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: A mechanism for obesity-associated colorectal cancer,” Journal of Nutritional Biochemistry, vol. 23, no. 10, pp. 1207–1213, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. M. B. S. Flores, G. Z. Rocha, D. M. Damas-Souza et al., “Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice,” Gastroenterology, vol. 143, no. 3, pp. 741–753, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. J. L. McClellan, J. M. Davis, J. L. Steiner et al., “Intestinal inflammatory cytokine response in relation to tumorigenesis in the ApcMin/+ mouse,” Cytokine, vol. 57, no. 1, pp. 113–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. K. T. Uysal, S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil, “Protection from obesity-induced insulin resistance in mice lacking TNF-α function,” Nature, vol. 389, no. 6651, pp. 610–614, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. R. K. Joshi and S.-A. Lee, “Obesity related adipokines and colorectal cancer: a review and meta-analysis,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 1, pp. 397–405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Kühnel, F. Taugner, B. Scholtka, and P. Steinberg, “Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats,” Archives of Toxicology, vol. 83, no. 8, pp. 763–768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. W. K. Chung, K. Belfi, M. Chua et al., “Heterozygosity for Lepob or Leprdb affects body composition and leptin homeostasis in adult mice,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 274, no. 4, pp. R985–R990, 1998. View at Google Scholar · View at Scopus
  75. C. T. Montague, I. S. Farooqi, J. P. Whitehead et al., “Congenital leptin deficiency is associated with severe early-onset obesity in humans,” Nature, vol. 387, no. 6636, pp. 903–908, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. I. S. Farooqi, J. M. Keogh, S. Kamath et al., “Partial leptin deficiency and human adiposity,” Nature, vol. 414, no. 6859, pp. 34–35, 2001. View at Google Scholar